U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07039981) titled 'Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Adults With Type 2 Diabetes' on June 10.
Brief Summary: The purpose of the study is to assess the safety and efficacy of a next generation automated insulin delivery algorithm in adults with type 2 diabetes aged 16-70 years old
Study Start Date: June 20
Study Type: INTERVENTIONAL
Condition:
Diabetes Mellitus
Intervention:
DEVICE: Omnipod M system
The Omnipod M system will allow user to use a lower glucose target and improve systems glucose control
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Insulet Corporation
Disclaimer: Curated...